+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Evonik Industries AG (EVK) - Financial and Strategic SWOT Analysis Review

Evonik Industries AG (EVK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Evonik Industries AG (Evonik), a subsidiary of RAG-Stiftung, is a specialty chemical company. Its product portfolio includes surfactants, polymers, resins, additives and others. The company’s products find application in various markets including agriculture, renewable energy, paints and coatings, paper and printings, metal and oil products, electrical and electronics, food and animal feed, consumer and personal care products, pharmaceuticals, plastics and rubber, automotive and construction. It also offers process technology, technical, logistics, utilities and waste management, and engineering services. Evonik has major production facilities in Germany, Belgium, the US, China and Singapore. The company has operations in North America, Asia-Pacific, Africa, South America, Europe and others. Evonik is headquartered in Essen, Nordrhein-Westfalen, Germany.

Evonik Industries AG Key Recent Developments

  • Mar 29, 2023: Evonik underpins leading position in drug delivery for RNA therapeutics with start of construction of new U.S. facility for pharmaceutical lipids
  • Feb 02, 2023: Evonik and EnBW sign another long-term purchase agreement for power supply from the “He Dreiht” offshore wind farm
  • Jan 31, 2023: Evonik invests €25m in methionine intermediates production plant upgrade in Wesseling/Germany
  • Dec 07, 2022: New CFO at Evonik: Maike Schuh succeeds Ute Wolf

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Evonik Industries AG - Key Facts
  • Evonik Industries AG - Key Employees
  • Evonik Industries AG - Key Employee Biographies
  • Evonik Industries AG - Major Products and Services
  • Evonik Industries AG - History
  • Evonik Industries AG - Company Statement
  • Evonik Industries AG - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Evonik Industries AG - Business Description
  • Business Segment: Nutrition & Care
  • Overview
  • Performance
  • Business Segment: Other Activities
  • Performance
  • Business Segment: Performance Materials
  • Overview
  • Performance
  • Business Segment: Smart Materials
  • Overview
  • Performance
  • Business Segment: Specialty Additives
  • Overview
  • Performance
  • Business Segment: Technology & Infrastructure
  • Overview
  • Performance
  • Geographical Segment: Asia-Pacific
  • Performance
  • Geographical Segment: Central & South America
  • Performance
  • Geographical Segment: Europe, Middle East & Africa
  • Performance
  • Geographical Segment: North America
  • Performance
  • R&D Overview
  • Evonik Industries AG - Corporate Strategy
  • Evonik Industries AG - SWOT Analysis
  • SWOT Analysis - Overview
  • Evonik Industries AG - Strengths
  • Evonik Industries AG - Weaknesses
  • Evonik Industries AG - Opportunities
  • Evonik Industries AG - Threats
  • Evonik Industries AG - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences, Power Financial Deals and Alliances
  • Evonik Industries AG, Petrochemicals, Deals By Year, 2017 to YTD 2023
  • Evonik Industries AG, Petrochemicals, Deals By Type, 2017 to YTD 2023
  • Evonik Industries AG, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Mar 29, 2023: Evonik underpins leading position in drug delivery for RNA therapeutics with start of construction of new U.S. facility for pharmaceutical lipids
  • Feb 02, 2023: Evonik and EnBW sign another long-term purchase agreement for power supply from the “He Dreiht” offshore wind farm
  • Jan 31, 2023: Evonik invests €25m in methionine intermediates production plant upgrade in Wesseling/Germany
  • Dec 07, 2022: New CFO at Evonik: Maike Schuh succeeds Ute Wolf
  • Nov 08, 2022: Evonik 3rd Quarter 2022 Results
  • Nov 03, 2022: Wind energy from the North Sea: Evonik and EnBW sign a long-term supply contract for electricity from offshore wind farm He Dreiht
  • Sep 15, 2022: Lithium from electric vehicle batteries: Moving towards better recycling
  • Aug 31, 2022: Evonik and Shell reduce heavy duty transport CO2e emissions with Bio-LNG
  • Aug 19, 2022: Evonik grows strongly in the first half of the year and confirms outlook for adjusted EBITDA for 2022
  • Aug 08, 2022: Evonik is substituting up to 40 percent natural gas at its German sites
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Evonik Industries AG, Key Facts
  • Evonik Industries AG, Key Employees
  • Evonik Industries AG, Key Employee Biographies
  • Evonik Industries AG, Major Products and Services
  • Evonik Industries AG, History
  • Evonik Industries AG, Other Locations
  • Evonik Industries AG, Subsidiaries
  • Evonik Industries AG, Joint Venture
  • Evonik Industries AG, Key Competitors
  • Evonik Industries AG, Ratios based on current share price
  • Evonik Industries AG, Annual Ratios
  • Evonik Industries AG, Interim Ratios
  • Evonik Industries AG, Petrochemicals, Deals By Year, 2017 to YTD 2023
  • Evonik Industries AG, Petrochemicals, Deals By Type, 2017 to YTD 2023
  • Evonik Industries AG, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Evonik Industries AG, Performance Chart (2018 - 2022)
  • Evonik Industries AG, Ratio Charts
  • Evonik Industries AG, Petrochemicals, Deals By Year, 2017 to YTD 2023
  • Evonik Industries AG, Petrochemicals, Deals by Type, 2017 to YTD 2023

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • BASF SE
  • DuPont de Nemours Inc
  • Akzo Nobel NV
  • Lanxess AG
  • PCAS
  • Ecovyst Inc
  • Solvay SA
  • Eastman Chemical Co
  • Akzo Nobel NV
  • BASF SE
  • DuPont de Nemours Inc
  • Eastman Chemical Co
  • Ecovyst Inc
  • Lanxess AG
  • OQ Chemicals GmbH
  • PCAS
  • Solvay SA
  • OQ Chemicals GmbH